New products and better distribution drive Wright Medical
This article was originally published in Clinica
Alcon has reported healthy quarterly sales growth of its surgical products (up 6% to $371m), intraocular lenses (up 9% to $114m) and cataract and vitrectomy equipment and disposable products (up 8% to $86m). However, its refractive revenues plummeted by 33% to $16m - a slump prompted by adverse global economic conditions and "weak consumer confidence", says the company's president and CEO Tim Sear. Mr Sear maintained that the company's refractive sales, which currently account for less than 3% of total Alcon's sales, should resume a growth trend as the economy picks up.
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.